AZORRA LLC Revolutionizes Staghorn Calculus Management with Innovative New Device

Fort Lauderdale, FL – October 26, 2023 – AZORRA LLC, a medical device company based in Fort Lauderdale, Florida, is making waves in the urology field with the launch of a groundbreaking new device specifically designed to address the challenging issue of staghorn calculi – large, branched kidney stones. For years, urologists have struggled with the complexities of effectively and safely removing these troublesome formations, often relying on multiple procedures and prolonged hospital stays. AZORRA’s new device promises to change that. The Staghorn Calculus Challenge – And Why AZORRA Stepped Up Staghorn calculi get their name from their resemblance to the antlers of a stag. They’re complex, often filling a large portion of the kidney. Traditionally, treating them meant either open surgery – a pretty major procedure – or a series of less invasive treatments like shock wave lithotripsy (breaking the stones with sound waves) and ureteroscopy (using a small scope to remove fragments). But these methods often leave behind residual fragments, requiring repeat procedures. It’s a real headache for both patients and doctors. "We saw a clear need for a better solution," explains Dr. Evelyn Reed, Chief Medical Officer at AZORRA LLC. “Patients were suffering through multiple interventions, and doctors were facing lengthy, complicated procedures. We asked ourselves, ‘How can we simplify this and improve outcomes?’” AZORRA LLC, established with a mission to innovate in minimally invasive medical devices, decided to tackle the staghorn calculus problem head-on. Located at 201 E Las Olas Blvd Ste 2250, Fort Lauderdale, FL, 33301-4449, and reachable at 318-468-6734, the company boasts a team of engineers and clinicians dedicated to developing cutting-edge solutions. They’ve spent the last several years designing, prototyping, and rigorously testing their new device, and the results are impressive. Introducing the AZORRA Staghorn Extraction System (ASES) The ASES isn’t just another stone removal tool. It’s a complete system designed to navigate the complexities of staghorn calculi with precision and efficiency. Here's how it works, in plain language: Advanced Navigation: The core of the ASES is a flexible, steerable catheter. Think of it like a tiny, high-tech snake. This catheter can be guided through the urinary tract and directly into the kidney, even navigating tight turns and complex anatomy. It's equipped with real-time imaging capabilities allowing the urologist to see exactly where the tip of the catheter is at all times. Multi-Modal Fragmentation: The ASES isn’t relying on just one way to break up stones. It combines several techniques: Laser Lithotripsy: A high-powered laser fiber delivers precise energy to pulverize the stone into smaller fragments. This is a standard technique, but the ASES design optimizes laser delivery for maximum effectiveness within the complex staghorn structure. Pneumatic Pulsation: The ASES can also deliver controlled bursts of pneumatic energy (air pressure) to help dislodge and fragment stone material. This is particularly useful for breaking up larger chunks and clearing debris. Mechanical Disruption: A small, articulating basket is integrated into the catheter tip. This basket can be used to actively grasp and remove larger stone fragments. Integrated Suction & Irrigation: As the stone is fragmented and removed, the ASES simultaneously provides high-speed irrigation to flush away debris and powerful suction to remove fragments. This keeps the surgical field clear and improves visibility. Real-Time Imaging & Mapping: The system links with standard fluoroscopy and C-arm imaging, and it's designed for potential integration with advanced imaging modalities like intraoperative ultrasound. This gives the surgeon a complete 3D view of the kidney and the stone, allowing for precise targeting and navigation. A digital mapping feature records the stone's structure and fragmentation progress, helping to ensure complete stone removal. What Does This Mean for Patients? The AZORRA Staghorn Extraction System is designed to dramatically improve the patient experience. Here’s what patients can expect: Shorter Procedure Times: The system’s efficiency reduces the time spent in the operating room. Reduced Hospital Stays: Faster procedures often mean patients can go home sooner. Less Pain & Discomfort: The minimally invasive approach minimizes trauma to surrounding tissues. Higher Stone-Free Rates: The comprehensive fragmentation and removal capabilities increase the likelihood of complete stone removal, reducing the need for repeat procedures. Improved Quality of Life: Removing the stone relieves pain, prevents complications, and improves overall kidney function. “We’re not just trying to make the procedure faster,” Dr. Reed emphasizes. “We want to make it better for the patient – less traumatic, less painful, and with a higher chance of long-term success.” Early Results are Promising AZORRA LLC has completed initial clinical trials of the ASES, and the results are encouraging. Data shows a significant reduction in procedure time and hospital stays compared to traditional methods. Furthermore, early stone-free rates are exceeding expectations. The company is currently seeking FDA clearance for the device and plans to begin commercial distribution in early 2024. AZORRA LLC – Pioneering Minimally Invasive Solutions AZORRA LLC isn’t stopping with the ASES. The company is committed to ongoing research and development to create innovative solutions for a wide range of urological conditions. They believe that minimally invasive technology holds the key to improving patient care and outcomes. With a dedicated team and a passion for innovation, AZORRA LLC is poised to become a leader in the medical device industry. For more information about AZORRA LLC and the ASES, please visit [Company Website - Placeholder] or contact them at 318-468-6734.